ArticleAmerican journal of cancer research2016

Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer.

Vince Kornél Grolmusz et al.PubMed ↗Full text ↗

No numbers read from the abstract.